Stock chart
Ticker: OMED Exchange: NSM


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2018-12-26 2018-12-24 S Sale

Gurney Austin

See Remarks

Officer
11,117 -14.3%
0.60
USD 6,669
11,117 -14.3% 0.60 USD 6,669
2018-10-11 2018-10-10 S Sale

Li Yvonne

See Remarks

Officer
927 -1.5%
2.02
USD 1,873
927 -1.5% 2.02 USD 1,873
2018-10-11 2018-10-10 S Sale

Stagg Robert

SVP, Clinical R&D

Officer
927 -2.2%
2.01
USD 1,863
927 -2.2% 2.01 USD 1,863
2018-10-11 2018-10-10 S Sale

Lewicki John A.

President & CEO

Executive Director
1,156 -2.0%
2.01
USD 2,324
1,156 -2.0% 2.01 USD 2,324
2018-10-11 2018-10-10 S Sale

Hager Alicia J.

SVP & General Counsel

Officer
1,156 -2.2%
2.02
USD 2,335
1,156 -2.2% 2.02 USD 2,335
2018-10-11 2018-10-10 S Sale

Gurney Austin

See Remarks

Officer
1,156 -1.5%
2.01
USD 2,324
1,156 -1.5% 2.01 USD 2,324
2018-10-10 2018-10-09 S Sale

Stagg Robert

SVP, Clinical R&D

Officer
1,686 -3.9%
2.13
USD 3,589
1,686 -3.9% 2.13 USD 3,589
2018-10-10 2018-10-09 PS Planned sale

Li Yvonne

See Remarks

Officer
1,229 -2.0%
2.13
USD 2,616
1,229 -2.0% 2.13 USD 2,616
2018-10-10 2018-10-09 PS Planned sale

Gurney Austin

See Remarks

Officer
1,686 -2.1%
2.13
USD 3,589
1,686 -2.1% 2.13 USD 3,589
2018-10-10 2018-10-09 PS Planned sale

Lewicki John A.

President & CEO

Executive Director
2,296 -3.9%
2.13
USD 4,888
2,296 -3.9% 2.13 USD 4,888
2018-10-10 2018-10-09 S Sale

Hager Alicia J.

SVP & General Counsel

Officer
1,686 -3.1%
2.13
USD 3,589
1,686 -3.1% 2.13 USD 3,589
2018-04-26 2018-04-24 S Sale

Stagg Robert

SVP, Clinical R&D

4,051 -8.6%
2.68
USD 10,848
4,051 -8.6% 2.68 USD 10,848
2018-04-26 2018-04-24 S Sale

Lewicki John A.

President & CEO

Executive Director
4,557 -7.6%
2.68
USD 12,202
4,557 -7.6% 2.68 USD 12,202
2018-04-26 2018-04-24 S Sale

Gurney Austin

See Remarks

4,051 -5.0%
2.68
USD 10,848
4,051 -5.0% 2.68 USD 10,848
2018-04-26 2018-04-24 S Sale

Li Yvonne

See Remarks

5,062 -7.8%
2.68
USD 13,555
5,062 -7.8% 2.68 USD 13,555
2018-04-26 2018-04-24 S Sale

Hager Alicia J.

SVP & General Counsel

4,051 -6.9%
2.68
USD 10,848
4,051 -6.9% 2.68 USD 10,848
2017-10-12 2017-10-10 S Sale

Hager Alicia J.

SVP & General Counsel

1,202 -2.0%
4.24
USD 5,099
1,202 -2.0% 4.24 USD 5,099
2017-10-12 2017-10-10 S Sale

Hager Alicia J.

SVP & General Counsel

46 -0.1%
4.26
USD 196
46 -0.1% 4.26 USD 196
2017-10-12 2017-10-10 S Sale

Patel Sunil

See Remarks

1,202 -1.7%
4.24
USD 5,099
1,202 -1.7% 4.24 USD 5,099
2017-10-12 2017-10-10 S Sale

Patel Sunil

See Remarks

46 -0.1%
4.27
USD 196
46 -0.1% 4.27 USD 196
// ... existing code ...